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Energy-Related Pollutants in the
Environment: Use of Short-Term Tests
for Mutagenicity in the Isolation and
Identification of Biohazards
by J. L. Epler,* F. W. Larimer,* T. K. Rao,* C. E. Nix,*
and T. Ho*
In an effort to gather information on the potential genetic hazards of existing or proposed energy-
generating or-conversion systems, we havebegun acorrelated analytical and geneticanalysis ofanumber
oftechnologies. The work is divided into two phases: one deals with known compounds expected to occur
in the environment through energy production, conversion, or use; the other deals with actual samples
from existing or experimental processes. To approach the problems of coping with and testing large
numbers of compounds, we set up a form of the "tier system." Operating units utilizing Salmonella,
Escherichia coli, yeast, human leukocytes, mammalian cefls, and Drosophila have been initiated.
Various liquid-liquid extraction methods and column chromatographic separations have been applied to
crude products and effluents from oil-shale, coal-liquefaction, and coal-gasification processes.
Mutagenicityofthe various fractions is assayedby meansofreversion ofhistidine-requiring auxotrophsof
Salmonella typhimurium; comparative studies are-carried out with the other genetic systems. In order
to incorporate metabolic activation of these fractions and compounds, rat liver homogenates (S-9) are
used in the various assays. Results implicate chemicals occurring in the basic (ether-soluble) and the
neutral fractions as potential genetic hazards. Chemical constituents of these fractions (identified or
predkted) were tested individually for their mutagenic activity.
Introduction
Industrial activity in the modern world has
created a large number of chemical pollutants. In
addition to obvious toxic effects, chemical pollu-
tants may also produce carcinogenic, mutagenic, or
teratogenic effects whose expression may be di-
vorced in time from the actual exposure(s). How-
ever, this chemical exposure does not originate
from only industrial processes. Table 1 lists a wide
variety of human exposure to chemicals that may
conceivably have an impact on human health. Thus,
thousands, perhaps tens ofthousands, ofchemicals
have the potential for affecting the population. Al-
though the health effects of a small list ofchemicals
in the environment are being studied extensively, it
has become obvious that methods to cut down the
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research time and expense are necessary to permit
evaluation of the large number of potentially
hazardous substances.
To investigate the potential genetic (and car-
cinogenic) hazards associated with the developing
synthetic fuel technologies, we initiated a coupled
chemical and biological analysis of the products,
process streams, and effluents of the existing or
proposed energy-generating or -conversion sys-
tems. One phase of our investigation deals with
known compounds expected to occur in the envi-
ronment through energy production, conversion, or
use; another phase deals with actual samples from
existing or experimental processes. To approach
the problems ofcoping with and testing large num-
bers of compounds, we set up a "tier system" of
mutagenicity testing.
The research effort described here is specifically
concerned with the question ofgenetic hazard; but,
as has been pointed out recently (1), certain micro-
11Table 1. General classes of chemicals to which humans are ex-
posed: potential environmental mutagens.
Drugs
Medicinal
Veterinary
Cosmetics
Pesticides
Stimulants
Food
Additives
Dyes
Preservatives
Sweeteners
Industrial products and effluents
Energy-related effluents
Energy production
Energy conversion
Energy use
Natural products
bial genetic assays (forexample, the Ames test with
Salmonella) show a high correlation between posi-
tive results in mutagenicity testing and the car-
cinogenicity of the compounds under test. The
overall need to subject environmental chemicals to
mutagenicity testing has been discussed in the
Committee 17 Report on Environmental Mutagenic
Hazards (2). Their key recommendation can be
summarized as follows: "Screening should be initi-
ated as rapidly and as extensively as possible." de
Serres has discussed the utility of short-term tests
for mutagenicity (3) and the prospect fortheiruse in
toxicological evaluation (4). He stresses that the
data base of knowledge on untested environmental
chemicals should be expanded, but cautions that we
are not ready to extrapolate directly from data ob-
tained in short-term tests for mutagenicity directly
to man (4). Tests on other organisms must be per-
formed to validate and reinforce results from
short-term tests, which simply point out potential
mutagenic and carcinogenic chemicals and serve to
order priorities for further testing in higher or-
ganisms.
Battery of Tests: First Tier
Obviously, all ofthe chemical pollutants in ques-
tion cannot be subjected to whole-animal testing.
The expense in time and money would be over-
whelming with genetic testing alone. We felt a
scheme had to be developed which would reliably
prescreen the genetically hazardous compounds
and allow the investigator to select a smaller sample
to be thoroughly tested in other systems. One
example ofsuch a battery oftests is shown in Table
2. A leveled or tiered system of testing [suggested
by Bridges (5, 6)] would save considerable time and
expense, while bringing the pertinent information to
the industrial community and the generalpopulation
in an organized and rapid manner. Ifthe correlation
of genetic damage with potential cancer danger is
valid, additional information would be obtained,
and conceivably, the choice of compounds to be
subjected to extensive carcinogenic testing in the
whole animal would be influenced.
Perhaps most important in a tiered system of
screening is the initial level of testing. False nega-
tives here presumably would terminate the testing
of any particular compounds, while false positives
would be clarified by further comparative testing.
Thus, the initial test should be a high-resolution,
sensitive assay, yet rapid and inexpensive. The
Salmonella histidine reversion system (7) probably
fits these criteria best of the currently available
short-term assays.
Known mutagens have different mechanisms of
action. The Salmonella tester strains detect and
differentiate the various mechanisms by their spec-
trum ofreversion. Mutagens like nitrous acid alter a
single base inthe DNA. Subsequenttranscription of
the altered codon leads to insertion of the wrong
amino acid into a polypeptide chain-a missense
mutation. Other mutagens (e.g., proflavin) have a
mechanism of action that results in the addition or
deletion of one or more base pairs in the DNA
molecule; these are classified as frame-shift muta-
gens. The reading frame (one amino acid codedby a
triplet of bases) is shifted by the base addition or
deletion. Thus, the frame ofreference is improperly
chosen, and a chain of improper amino acids is
coded and synthesized.
The Salmonella tester series (obtained through
the courtesy ofBruce N. Ames and shown in Table
3) is composed ofhistidine mutants that revert after
treatment with mutagens to the wild-type state
(growth independent of histidine). Both missense
mutants and frame-shift mutants comprise the set,
and their reversion characteristics with a potential
chemical mutagen imply the mechanism of action.
In addition, the detection scheme yields the highest
resolution possible by the inclusion of other muta-
tions: the deep rough mutation, rfa, which affects
the lipopolysaccharide coat, making the bacteria
more permeable; and the deletion of the uvrB re-
gion, eliminating the excision-repair system (8). The
procedures with the strains and their use in
mutagenicity testing have been discussed in detail
by Ames, McCann, and Yamasaki (7).
Generalized testing of compounds is ac-
complished by use of the three standard tester
strains, TA1535, TA1537, and TA1538, in combina-
tion with the R-factor strains TA100 and TA98
(plasmid-carrying strains with increased sensitiv-
ity). Briefly, the compound to be tested is dissolved
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Tier Gene mutation Chromosomal
Tier I
S. typhimurium Yeast
Histidine reversion Gene conversion
Forward mutation Mitotic recombination
E. coli Plants(?)
trp- reversion (WP2) Allium
Mohn system Tradescantia
Maize (waxy)
B. subtilis
E. coli DNA repair assays
S. typhimurium
Yeast
Reverse mutation
Forward mutation
Tier II
Drosophila Drosophila
Visibles X-chromosome loss
Sex-linked recessive lethals Nondisjunction
Mammalian cells (in culture) Mammalian cells
Mutagenesis Chromatid aberrations
DNA repair Sister-chromatid exchange
Mouse Mouse
The "spot test" Dominant lethals(?)
Heritable translocations
Higher Tiers
Mouse Mouse
Specific-locus test Heritable translocations
Chromosome loss
New mammalian tests??
a See text for references to various assays.
Table 3. Genotype of Salmonella typhimurium tester strains.
Additional mutations
Histidine mutation rfalAuvrB rfa/AuvrBl+R
hisG46 TA1535 TAIOO
hisC3076 TA1537
hisD3052 TA1538 TA98
in dimethyl sulfoxide or buffer. Concentration is
varied over a range of 1-500 ,ug added per plate
except with highly toxic compounds. The various
Salmonella strains are usually treated by use ofthe
plate-incorporation assay of Ames (7), but other
modified assays or assays for forward mutation can
be used (9).
One other feature ofthe Salmonella system is the
ease with which metabolic activation can be incor-
porated into the assay. Spot tests or quantitative
plate tests can be performed in the presence of rat
or other mammalian liver homogenates so that the
mutagen can be metabolized to its ultimate, active
form in the in vitro short-term test. In assays re-
quiring activation, standard rat liver microsome
preparations (7) from rats induced with Aroclor
1254 (Monsanto Corp.), sodium phenobarbital, or
other inducers are used.
As an initial step in establishing testing proce-
dures, we have investigated the use of the Ames
Salmonella system with a large number ofenviron-
mentally important chemicals and effluents, princi-
pally those known or predicted to occur in energy
use, production, and/or conversion. However,
other microbial tests should be used in comparison
with the Salmonella results. Among these are
bacterial systems, such as the Escherichia coli WP2
tryptophan reversion assay (10), the sensitive fluc-
tuation test described by Green (11), and the multi-
ple end point system developed by Mohn (12).
For example, the Mohn system, employing a
well-characterized mutant ofE. coli K-12 (343/113),
has been utilized in our laboratory to test various
compounds that are eitheridentified or suspected to
occur in various products and effluents of the syn-
thetic fuel technologies. The mutation screening in-
volves reversion of an auxotrophic marker for ar-
ginine requirement to prototrophy (Arg+), induction
of a forward mutation leading to 5-methyl tryp-
tophan resistance (5 MTR), ability to utilize galac-
tose as sole carbon source (gal+), and a deletion in
gal R region resulting in a new auxotrophic muta-
tion for lysine requirement (gal+, lys-). Results can
be compared and correlated with the Ames test re-
sults.
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strains either proficient or deficient in DNA repair
are also widely used in this initial battery of tests.
Among these are the "rec-assay" of Kada (13) in
Bacillus subtilis, the assay using E. coli mutants
deficient in DNA polymerase (polA-) (14), and,
again, the Salmonella system (7) using strains with
DNA deficiencies in comparison with normal. The
common hypothesis is that bacterial strains that are
repair-deficient are much more sensitive to agents
that alter cellular DNA than are the parent strain,
wild-type or normal for DNA repair functions. Pre-
sumably, these same agents that preferentially alter
DNA are potential mutagens and carcinogens.
Neurospora (15) and yeast (16) are also useful
tools in mutagenicity screening. Many laboratories
utilize the yeast strains developed by Zimmermann
for detecting mitotic recombination and mitotic
gene conversion along with assays for forward mu-
tation and reverse mutation. We have chosen to de-
velop acomprehensive gene mutation system (17) in
Saccharomyces cerevisiae, somewhat analogous to
the bacterial systems described.
A haploid yeast of genotype a; rad2-1; CANI,
hisl-7, hom3-10; lysI-l; trpS48; ade2-1 is the basis
ofthe reversion test system. This strain is defective
in DNA excision-repair. General forward mutation
can also be detected by selecting canavanine-
resistant clones (CAN] -* cani).
Base-pair substitution is monitored by observing
the reversion of missense (hisl-7) and nonsense
(lysl-l, trpS48, ade2-1) markers and by the genera-
tion of nonsense suppressors (various tRNA loci).
Additions or deletions ofbase pairs are indicated by
the reversion ofa frame-shift (?) marker (hom3-10).
Nonsense suppressors can also arise by addition/
deletion. Metabolic activation of promutagens is
provided by rat liver microsome preparations.
Thus, a battery of short-term microbial tests
comprised ofa selection ofthe above or other simi-
lar assays yields preliminary information on the
question ofwhether or not the substance under test
inflicts genetic damage at the highest level of reso-
lution possible.
Tests with Higher Organisms: A
Second Tier
At a second level of testing with selected com-
pounds from the microbial screens (including some
negatives) orwithcompounds ofhighimportance or
interest to man, the question becomes one of the
mutagenicity ofthe compound in higher organisms.
Because ofthe expense ofthese assays in both time
and money, the probability ofexposure and the ac-
tual intake by man may become deciding factors.
The key objective of the approach is to gain suffi-
cient information to enable the investigator to com-
pare and eventually extrapolate from one system to
another.
The Drosophila (insect) system can be utilized as
a key assay at this level. The standard Basc, or
Muller-5 (18), test for sex-linked recessive lethals
can be used. Males are exposed to the test com-
pound by feeding, injection, or inhalation of an
aerosol, then mated to females, and finally removed
after a mating period. Females are allowed to lay
eggs for a period of days. F, heterozygous females
are scored for sex-linked lethals.
The insect assay is a sensitive system, since loci
throughout the length of the sex (X) chromosome
can mutate to recessive lethals. Furthermore, the
organism is diploid and possesses its own
metabolizing system for mutagens/carcinogens.
Additional genetic and cytogenetic end points can
easily be observed and quantitated (e.g., chromo-
some loss, nondisjunction, translocations, and in-
versions). Additionally, by mating the treated male
to a sequence of females, cells from various stages
of spermatogenesis at the time of treatment can be
assayed.
Mammalian somatic cell mutagenesis has pro-
gressed remarkably during recent years, although
considerable development and validation is still
necessary. The CHO/HGPRT system developed by
Hsie et al. (19) appears to be the most reliable and
promising. This system can be coupled to rat liver
microsomal preparations prepared as for the micro-
bial systems and used to detect the conversion of
promutagens (and procarcinogens) to their active
forms. DNA repair assays in mammalian cells (20,
21) are also highly sensitive and accurate predic-
tors.
Mammalian cytogenetic assays such as the in-
duction of aberrations in chromosomes of leuko-
cytes from human peripheral blood or of mamma-
lian cells in vitro are useful screens, as shown by
Ishidate (22). The relatively new assay of sister-
chromatid exchange (23) may be a most effective
tool with chemical agents. Again, however, exoge-
nous sources of metabolizing enzymes must be
added to detect promutagens.
At a second level or tier of testing, preliminary
assays with whole animals (the mouse) should be
initiated in order to address the question of
mutagenic potential for higher organisms. Although
the work of the Comparative Mutagenesis Unit at
Oak Ridge applies specifically to submammalian
systems and cultured mammalian cells, the mouse
assay will be briefly outlined here.
The dominant lethal assay (24) can be included as
a potential screen. In this relatively rapid test for
Environmental Health Perspectives 14chromosomal damage, different germ cell stages
can be compared with respect to their sensitivity to
the sample. This is done by studying uterine con-
tents offemales mated to exposed males at various
intervals after the exposure. Another potentially
useful assay for the whole animal involves the de-
tection of somatic mutations in vivo, the so-called
"spot test" designed by Russell (25). Embryos
heterozygous for the same markers that are used in
the specific-locus test (26) are exposed to the puta-
tive mutagen. Genetic changes that uncover the re-
cessive at these loci are detected as spots ofaltered
color in the fur. Since each animal scored repre-
sents several hundred cells in which the genetic
changes could have occurred, the method combines
the advantages of cell culture with an in vivo sys-
tem. It can probably be used as aprescreen to select
materials for use in the specific-locus test described
below.
HigherTiers: Risk Assessment (?)
Although only selected compounds would be
tested in depth in the mammalian assays, these
systems are the closest available bridge to actual
risk assessment in human populations (2). Based on
data accumulated in submammalian systems, gene
mutation and cytogenetic data from cultured mam-
malian cells, and the preliminary whole-animal data
from the "second tier," reasonable decisions to
carry out more complex and expensive mammalian
testing can be made. Data from, e.g., heritable
translocations and the specific locus test in the
mouse might prove most useful. The search for
heritable genetic changes in mammalian germ cells
may be the most critical and definitive one for the
assessment of genetic risk to human beings.
The heritable translocation method (24) measures
the frequency of chromosome breakage and rear-
rangement that is transmitted to the next genera-
tion. The test is a sensitive and reliable procedure
for measuring breakage and exchange of parts be-
tween chromosomes induced in male germ cells.
When a sperm carrying chromosome interchange is
used in fertilization, the resulting progeny is
heterozygous for the translocation and produces
two types ofgametes, balanced and unbalanced, in
approximately equal proportions. Both types of
gametes are capable of fertilization, but the unbal-
anced gametes result in embryonic lethality-i.e.,
translocation heterozygotes are only half as fertile
as normal mice. In the heritable translocation pro-
cedure progeny oftreated parents are simply tested
for sterility and partial sterility. Confirmed sterile
and partially sterile progeny are then verified
cytologically for presence of a translocation. Thus,
the heritable translocation procedure generates
meaningful information for evaluating chromosome
aberration hazards of test agents to the human
population because it measures transmissible ge-
netic damage.
In the specific-locus method, induced mutations
can be objectively detected inthe firstgenerationby
mating exposed mice to a stock carrying seven re-
cessive markers.in homozygous condition (26). This
is the only practical method available to detect gene
mutations in the germ cells of mammals and to de-
termine their rate of induction by a given agent.
The use ofavariety oftests on a series ofselected
compounds under standard conditions should allow
a meaningful comparison between the less expen-
sive and more rapid tests on microorganisms and
the more definitive tests for effects in the mammal.
Such a comparison will allow greater confidence to
be placed in the tests on lower organisms, thus re-
ducing the future effort required. Only such a com-
parative approach will allow rational decisions to be
made between different testing and screening
schemes.
The assays used here are discussed in detail in the
series edited by Hollaender (27). Note that both
gene mutation and chromosomal assays are in-
cluded and that testing involves a move from the
simple microbial tests (Salmonella, E. coli, and
yeast), to tests with higher organisms (Drosophila,
mammalian cells, human leukocytes), to tests with
the whole mammal, presumably the mouse. Thus, if
the testing priorities are established on the basis of
use by or impact on man, complete testing may be
reduced to groups of environmentally important
compounds, e.g., selected polycyclic hydrocarbons
or nitrosamines.
Screening Results
As an example of the type of data that can be
derived from a comparative approach and the in-
formation that can be gained from such an ap-
proach, we list in Table 4 a group of substituted
nitroso compounds (N-nitrosopiperidines) that have
been assayed in both the Salmonella and yeast sys-
tems and then extended to the insect (Drosophila)
sex-linked lethal system. The carcinogenicity (if
known) is also listed. Note that all of the systems
show a high correlation ofmutagenic response with
carcinogenicity. Furthermore, the importance of
metabolic activation in the in vitro short-term as-
says should be stressed. The sensitivity of the
Drosophila system for detection of this class of
compounds appears to be high, with the fly supply-
ing its own metabolism; however, the sensitivity
breaks down when the oxygen-substituted com-
December 1978Table 4. Comparative mutagenicity of nitrosopiperidines.
S. typhimurium S. cerevisiae, D. melanogaster,
(plate assay), CANS--+canR or X-linked Carcinogenicity
Compound his--his+ his-+his+ recessive lethals rats
N-Nitrosopiperidine (NP) + + + +
2-Methyl NP + + + +
3-Methyl NP + + + +
4-Methyl NP + + + +
3,5-Dimethyl NP + + + +
2,6-Dimethyl NP
3,4-Dehydro NP + + + +
3-Chloro NP + +. + +
3,4-Dichloro NP + + + +
3,4-Dibromo NP + + + +
Nitroso-4-piperidinol + - - +
Nitroso-4-piperidone + - - +
Nitrosopipecolic acid
Nitrosoguvacoline + not tested
pounds are tested. Although positive for
mutagenicity in the microbial systems, these car-
cinogenic compounds are negative in Drosophila.
The usefulness of the assays from the view of
structure-function relationships is also illustrated,
i.e., nitroso-containing ring structures blocked in
the positions alpha to the N-nitroso group show
either a reduction or elimination ofmutagenicity as
well as carcinogenicity (17, 28, 29).
The potential usefulness ofthe Ames histidine re-
version system as a prescreen is iilustrated in Table
5. The large group ofcompounds eitheridentified or
suspected to occur in various energy-related
effluents or products is listed with respect to
mutagenicity in the Salmonella test. The unan-
swered question at this point is whether the testing
of negative compounds can sensibly be terminated
here (30).
Screening of Complex Mixtures
To determine rapidly the potential biohazards
(mutagenicity/carcinogenicity?) of various crude
and complex test materials derived from fossil fuel
production or conversion activities, we have ex-
amined the feasibility of using short-term genetic
assays to predict, isolate, and identify the chemical
hazards. The biological screening assay was
coupled to an analytical chemistry separation pro-
cedure so that the chemical work and priorities for
identification could be determined by the bioassay.
Again, the wide applicability of the bacterial test
system developed by Ames can be demonstrated by
the use of the assay as a prescreen for potential
genetic hazards ofcomplex environmental effluents
or products [e.g., tobacco smoke condensates (31),
hairdyes (32), sootfromcity air(7), fly ash (33), and
(in our work) oils and aqueous wastes from syn-
thetic fuel technologies (30, 34)].
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Table 5. Mutagenic activity of coal fraction constituents
(predicted or identified).a
Strain Mutagen
Anthracene 100
Benz[a]anthracene 100 +
Benz[b]anthracene 100 +
7,12-Dimethyl[a]benzanthracene 100 +
1,2,3,4-Dibenzanthracene 100 +
1,2,5,6-Dibenzanthracene 100 +
Pyrene 1537 +
Benzo[a]pyrene 98 +
Chrysene 100 +
Fluoranthene 98 +
Phenanthrene 98 +
Fluorene 100
9-Methylfluorene 100
2,3-Benzofluorene 100 +
9-Methylanthracene 98 +
2-Aminoanthracene 100 +
Biphenyl 100
Diphenylamine 100
Isoquinoline 100
Acridineb 1537 +
Carbazole 100
a-Naphthylamine 100 +
2,6-Dimethylquinoxaline 100 -
2,3-Dimethylquinoxaline 100 -
Hydroquinone 100 -
Methylpyridine (picoline) 98, 100 -
Ethylpyridine 98, 100 -
Dimethylpyridine (lutidine) 98, 100 -
Trimethylpyridine
Bipyridine 98, 100 -
2,5-dimethylaniline 98, 100 +
Trimethylaniline 98, 100
Quinoline 98 +
7-Methylquinoline 100 +
8-Methylquinoline 100 +
2,6-Dimethylquinoline 98, 100
8-Hydroxyquinoline 100 +
8-Aminoquinoline 1537 +
8-Nitroquinoline 100 +
Dimethylpiperidines 98, 100
a Determined from plate assay, including metabolic activation
with Aroclor-induced liver.
b Metabolic activation was not necessary.
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testing to environmental effluents and crude prod-
ucts from the synthetic fuels technology, we at-
tempted to perform screening with the highly sen-
sitive Ames histidine reversion strains known to
respond to a wide variety of proven mutagens/
carcinogens. The working hypothesis was that sen-
sitive detection of potential mutagens in fraction-
ated complex mixtures could be used to isolate and
identify the biohazard. In addition, the information
could be helpful in establishing priorities for further
testing, either with other genetic assays or with car-
cinogenic assays. Finally, the procedures might
show utility in monitoring plant processes,
effluents, or personnel early in the formation ofthe
engineering and environmental technology that will
eventually evolve in the synthetic fuels industry.
The approach and preliminary results showed that
the coupled chemical-biological scheme is afeasible
research mechanism and is applicable to the ascer-
tainment ofpotential human health hazard ofawide
variety ofenvironmental exposures, either occupa-
tionally or to the population in general.
As an example of the screening of fractionated
complex mixtures, we list in Table 6 the results
from an aqueous sample containing a variety ofor-
ganic contaminants. The sample consists of the
condensate from an experimental coal gasification
process (supplied by the Pittsburgh Energy Re-
search Center). A large quantity of the aqueous
sample was extracted and subjected to fractionation
by the Stedman procedure (35). Previous publica-
tions have shown the usefulness of this technique
with crude petroleum oils, synthetic crude oils,
shale oils, and aqueous wastes (30, 34, 36).
Primary fractions were obtained as listed in
Table 6. The table shows the analytical weight
analysis of each fraction and lists the mutagenicity
test results both as a specific activity of each frac-
tion and as a weighted activity. Fractions and/or
control compounds to be tested were suspended
in dimethyl sulfoxide (supplied sterile, spec-
trophotometric grade from Schwarz/Mann) to con-
centrations in the range of 10-20 mg/ml solids. The
potential mutagenic fraction was in some cases as-
sayed for general toxicity (bacterial survival) with
strain TA1537. Normally, the fraction was tested
with the plate assay over at least a 1000-fold con-
centration range with the two tester strains TA98
andTA100. Revertantcolonies were counted after a
48-hr incubation. Data were recorded and plotted
versus added concentration, and the slope of the
induction curve was determined. It is assumed that
the slope of the linear dose-response range reflects
the mutagenic activity (specific activity). Positive or
questionable results were retested with a narrow
range of concentrations. All studies were carried
out with parallel series ofplates plus and minus the
rat liver enzyme preparation (7) for metabolic acti-
vation. Routine controls demonstrating the sterility
of samples, enzyme or rat liver 5-9 preparations,
and reagents were included. Positive controls with
known mutagens were also included in order to re-
check strain response and enzyme preparations. All
solvents used were nonmutagenic in the bacterial
test system. Additivity of the individual weighted
Table 6. Distribution of mutagenic activity in fractions of gasifler condensate.a
Activity"
Relative Specific Weighted
Fraction weight, activity, activity,
No. Fractionb (% oftotal) rev/mg rev/mgd
1 NaOH, Not collected
2 WA, 8.3 750 62
3 WAE 34.5 25 9
4 SA, 14.1 500 70
5 SAE 9.9 600 60
6 SAW 30.8 0 0
7 BIa 0.03 0 0
8 BIb 0.04 150 0
9 BE 0.5 4000 18
10 BW 0.1 Not tested
Neutral 1.9 100 2
Total 221
a All assays carried out in the presence of crude liver S-9 from rats induced with Aroclor 1254; 0.9% (w/v) of solids from 6 liters
extracted.
1bCode: I = insoluble (fractions a and b), E = ether-soluble, W = water-soluble, WA = weak acid, SA = strong acid, B = base.
c Rev/mg = revertants/mg, the numberofhistidine revertants fromSalmonella strainTA98 determinedby use ofthe plate assay with
2 x 108 bacteria per plate. Values are derived from the slope ofthe induction curve extrapolated to a milligram value.
d Weighted activity ofeach fraction relative to the starting material is the product ofrelative weight and specific activity. The sum of
these products is given as a measure ofthe total mutagenic potential ofthe material.
December 1978Table 7. Comparative mutagencity of Synfuel fractions.a
Test systemb
Drosophila
Saccharomyces melanogaster, Human
Salmonella E. coli cerevisiae, sex-linked CHO cells, leukocytes,
typhimurium, arg--arg+/or his--his+ or recessive 6-thioguanine chromosome Mu* musculus,
Test material his--his+ gal--gal+ CANs-.can5 lethals resistancec aberrations dominant lethalsd
Crude Synfuelc + NT NT NT NT NT +
Basic fraction + + + + + NT
Neutral fraction + + + - NT +? NT
a Liquid petroleum crude Synfuels of Pittsburgh Energy Research Center or FMC Corp.
b Code: (+) mutagenic; (-) nonmutagenic; (NT) not tested.
c A. W. Hsie, personal communication.
d W. M. Generoso, personal communication.
e Crude Synfuels are generally too toxic to test in most systems.
values was assumed, and a final total mutagenic
potential was calculated.
The values given in Table 6 represent the deter-
minations with strain TA98 metabolically activated
with an Aroclor-induced rat liver enzyme prepara-
tion. The total extracted 6 liters contained 0.9 wlvo
of solids yielding the various weight percent frac-
tions shown. Although in most cases crude samples
are too toxic to the bacterial assay to test in an
appropriate concentration range, the crude aqueous
condensate did show a positive effect with the
Ames system-a value of 60 revertants/100 gul of
condensate with strain TA98 and 75 revertants/
100,ul with strain TA100. The extracted concentrate
values are shown in Table 6. We assume that the
most accurate measure of the total mutagenic po-
tential of the test material is the sum of the tested
fractions, 221 revertants/mg of starting material
(solids). Acidic and basic components in the aque-
ous sample appear to contain the major mutagenic
components, in contrast to work with crude oils
where the neutral fractions, presumbly polyaro-
matic hydrocarbons, are also major contributors
(34).
In this initial feasibility study, however, the point
in question is not whether these results reflect a
relative biohazard for comparison with other mate-
rials or processes. The results simply show that
biological testing-the Ames histidine reversion
assay in this study-can be carried out with the
newly developed tester systems, but perhaps only
when coupled with the appropriate analytical sep-
aration scheme.
Comparative Mutagenesis of
Complex Mixtures
To validate and compare the results accumulated
in the Ames system with complex test materials
from synthetic fuel technologies, we selected
specific fractions or subfractions on the basis of
their activity in the histidine reversion assay for
further testing in the various assays described in the
section on the tier approach to testing. Preliminary
results have been published in the Proceedings of
the Second International Conference on Environ-
mental Mutagens, Edinburgh, 1977 (37). Qualitative
comparisons may be seen in Table 7. The selected
fractions or subfractions utilized were basic and
neutral isolates from synthetic crude oils from coal
liquefaction processes [Synfuel A and B as de-
scribed by Epler et al. (34)]. In Drosophila (38) and
in the mammalian cell gene mutation assay (39),
detection has been a function of newly developed
fractionation schemes (e.g., the use of LH-20) (40,
41) that result in higher-specific-activity (more
highly purified) mutagenic subfractions. In general,
the results validate the initial screening carried out
in the Salmonella assay, but they have not as yet
been used to exhaustively test materials that are
negative in the Ames system. Note, also, however,
that the preliminary results of Generoso (personal
communication) show that the crude synthetic fuel
does induce dominant lethals in mice, although the
basic fraction alone appears to be negative.
Conclusions-Precautions
The detection or perhaps the generation of
mutagenic activity may well be a function of the
chemical fractionation scheme utilized. The inabil-
ity to recover specific chemical classes or the for-
mation of artifacts by the treatment could well dis-
tort the results obtained, as could an inability to
detect the specific biological endpoint chosen.
Along with the obvious bias that could accompany
the choice ofsamples and theirsolubility orthe time
and method of storage, a number of biological dis-
Environmental Health Perspectivescrepancies could also enter into the determinations.
For example, concomitant bacterial toxicity could
nullify any genetic damage assay that might be car-
ried out; the choice ofinducerfor the liver enzymes
involved could be wrong for selected compounds;
or the choice of strain could be inappropriate to
selected compounds. Furthermore, the applicability
of the Salmonella test results to other genetic as-
says and the validation of the apparent correlation
between mutagenicity and carcinogenicity still
needs validation through sufficient fundamental re-
search. Furthermore, the short-term assays chroni-
cally show negative results with, e.g., heavy metals.
Similarly, compounds involved in or requiring
cocarcinogenic phenomena. would presumably go
undetected. However, as a prescreen to aid inves-
tigators in ordering their priorities, the short-term
tests appear to be a valid approach to testing the
large numberofhazardous compounds and complex
mixtures that man encounters in his environment.
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